Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Kinder

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
Seminars in Respiratory and Critical Care Medicine|September 18, 2025
The Evaluation of the Oncologic Patient for Drug-Induced PneumonitisTerra C Swanson, Brent W Kinder, Joshua M Clark
Lung|September 26, 2012
Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registryN Oprescu, F X McCormack, S Byrnes, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2010
Screening for lymphangioleiomyomatosis by high-resolution computed tomography in young, nonsmoking women presenting with spontaneous pneumothorax is cost-effectiveJared T Hagaman, Daniel P Schauer, Francis X McCormack, et al.
ACS Nano|May 17, 2017
Monolayer Solid-State Electrolyte for Electric Double Layer Gating of Graphene Field-Effect TransistorsKe Xu, Hao Lu, Erich W Kinder, et al.
ACS Nano|April 17, 2015
Reconfigurable Ion Gating of 2H-MoTe2 Field-Effect Transistors Using Poly(ethylene oxide)-CsClO4 Solid Polymer ElectrolyteHuilong Xu, Sara Fathipour, Erich W Kinder, et al.
ACS Applied Materials & Interfaces|July 18, 2017
Increasing the Room-Temperature Electric Double Layer Retention Time in Two-Dimensional Crystal FETsErich W Kinder, Ashley Fuller, Yu-Chuan Lin, et al.
Lung|July 20, 2012
Treatment of idiopathic pulmonary fibrosis with losartan: a pilot projectMarisa Couluris, Brent W Kinder, Ping Xu, et al.
Chest|December 12, 2007
Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosisBrent W Kinder, Kevin K Brown, Marvin I Schwarz, et al.
Respiratory Medicine|December 8, 2009
Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosisBrent W Kinder, A C Sherman, L R Young, et al.
Chest|March 4, 2009
Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosisBrent W Kinder, Kevin K Brown, Francis X McCormack, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
Seminars in Respiratory and Critical Care Medicine|September 18, 2025
The Evaluation of the Oncologic Patient for Drug-Induced PneumonitisTerra C Swanson, Brent W Kinder, Joshua M Clark
Lung|September 26, 2012
Clinical predictors of mortality and cause of death in lymphangioleiomyomatosis: a population-based registryN Oprescu, F X McCormack, S Byrnes, et al.
American Journal of Respiratory and Critical Care Medicine|February 20, 2010
Screening for lymphangioleiomyomatosis by high-resolution computed tomography in young, nonsmoking women presenting with spontaneous pneumothorax is cost-effectiveJared T Hagaman, Daniel P Schauer, Francis X McCormack, et al.
ACS Nano|May 17, 2017
Monolayer Solid-State Electrolyte for Electric Double Layer Gating of Graphene Field-Effect TransistorsKe Xu, Hao Lu, Erich W Kinder, et al.
ACS Nano|April 17, 2015
Reconfigurable Ion Gating of 2H-MoTe2 Field-Effect Transistors Using Poly(ethylene oxide)-CsClO4 Solid Polymer ElectrolyteHuilong Xu, Sara Fathipour, Erich W Kinder, et al.
ACS Applied Materials & Interfaces|July 18, 2017
Increasing the Room-Temperature Electric Double Layer Retention Time in Two-Dimensional Crystal FETsErich W Kinder, Ashley Fuller, Yu-Chuan Lin, et al.
Lung|July 20, 2012
Treatment of idiopathic pulmonary fibrosis with losartan: a pilot projectMarisa Couluris, Brent W Kinder, Ping Xu, et al.
Chest|December 12, 2007
Baseline BAL neutrophilia predicts early mortality in idiopathic pulmonary fibrosisBrent W Kinder, Kevin K Brown, Marvin I Schwarz, et al.
Respiratory Medicine|December 8, 2009
Predictors for clinical trial participation in the rare lung disease lymphangioleiomyomatosisBrent W Kinder, A C Sherman, L R Young, et al.
Chest|March 4, 2009
Serum surfactant protein-A is a strong predictor of early mortality in idiopathic pulmonary fibrosisBrent W Kinder, Kevin K Brown, Francis X McCormack, et al.
Pageof 3